AC BioScience

ACBS is a clinical stage biotech company focused on novel approaches to provide more effective treatments for solid tumor cancer patients

Immuno-oncology breakthrough for the treatment of Colorectal Cancer (ACB1801)


Angiogenic therapy increasing survival of metastatic Pancreatic Cancer patients (ACB2003.4)

About us

AC BioScience is a start-up biotech company headquarted at the life sciences Biopôle near Lausanne, with an innovative vision and business model.


Our “success by design” business model starts with the identification of new medical strategies for the treatment of cancer.


AC BioScience has three drugs in development for fighting cancer.


Archive of publications resulting from our research.